Trial · NCT03049618
Results by group39
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 39
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Overall Response Rate (ORR) | Head and Neck Cancer Cohort | 6 | Participants | ||
| Overall Response Rate (ORR) | Non-Small Cell Lung Cancer Cohort | 3 | Participants | ||
| Duration of Response | Head and Neck Cancer Cohort | 3.7 | 95% Confidence Interval 1.8 to 8.9 | Months | |
| Duration of Response | Non-Small Cell Lung Cancer Cohort | 7.6 | 95% Confidence Interval 1.6 to 28.0 | Months | |
| Number of Participants With Adverse Events | Head and Neck Cancer Cohort | CTCAE grade 1 or 2 | 25 | participants | |
| Number of Participants With Adverse Events | Non-Small Cell Lung Cancer Cohort | CTCAE grade 1 or 2 | 17 | participants | |
| Number of Participants With Adverse Events | Head and Neck Cancer Cohort | CTCAE grade 3 or 4 | 23 | participants | |
| Number of Participants With Adverse Events | Non-Small Cell Lung Cancer Cohort | CTCAE grade 3 or 4 | 17 | participants | |
| Overall Survival (OS) | Head and Neck Cancer Cohort | 8.6 | 95% Confidence Interval 3.2 to 13.7 | Months | |
| Overall Survival (OS) | Non-Small Cell Lung Cancer Cohort | 11.8 | 95% Confidence Interval 4.2 to 30.1 | Months | |
| Progression Free Survival (PFS) | Head and Neck Cancer Cohort | 2.6 | 95% Confidence Interval 1.3 to 4.1 | Months | |
| Progression Free Survival (PFS) | Non-Small Cell Lung Cancer Cohort | 3.0 | 95% Confidence Interval 1.2 to 6.1 | Months | |
| Association of Biomarker With Overall Response Rate - HPV Status | Head and Neck Cancer Cohort | HPV Negative who achieved CR/PR | 5 | Participants | |
| Association of Biomarker With Overall Response Rate - HPV Status | Head and Neck Cancer Cohort | HPV Positive who achieved CR/PR | 1 | Participants | |
| Association of Biomarker With Overall Response Rate - P16 Status | Head and Neck Cancer Cohort | P16 Negative who achieved CR/PR | 5 | Participants | |
| Association of Biomarker With Overall Response Rate - P16 Status | Head and Neck Cancer Cohort | P16 Positive who achieved CR/PR | 1 | Participants | |
| Association of Biomarkers With Overall Response Rate - EphrinB2 Status | Head and Neck Cancer Cohort | EphrinB2 Negative who achieved CR/PR | 9 | Participants | |
| Association of Biomarkers With Overall Response Rate - EphrinB2 Status | Head and Neck Cancer Cohort | EphrinB2 Positive who achieved CR/PR | 6 | Participants | |
| Association of Biomarkers With Overall Response Rate - PD-L1 Status | Head and Neck Cancer Cohort | PD-L1 Negative who achieved CR/PR | 3 | Participants | |
| Association of Biomarkers With Overall Response Rate - PD-L1 Status | Head and Neck Cancer Cohort | PD-L1 Positive who achieved CR/PR | 3 | Participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03049618/results